Automation and the Endangered Future of the Pap Test
Open Access
- 20 May 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 90 (10) , 738-749
- https://doi.org/10.1093/jnci/90.10.738
Abstract
Deaths from uterine cervical cancer have been dramatically reduced since the development in the 1940s of the Papanicolaou smear (also called the Pap smear or test) for detection of precursor lesions. Along with the vaccines for smallpox, polio, and other viruses, this screening test has been hailed as one of the most successful public health measures and is the only cancer screening test proved to reduce mortality (1).Keywords
This publication has 45 references indexed in Scilit:
- PAPNET Testing for HSILsActa Cytologica, 1998
- Multicenter Masked Evaluation of AutoCyte PREP Thin Layers with Matched Conventional SmearsActa Cytologica, 1998
- Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screeningObstetrics & Gynecology, 1997
- The Pap Smear on TrialLaboratory Medicine, 1997
- Appraising the Pap Smear: Will Society, Insurers, Put Their Money Where the Value Is?Laboratory Medicine, 1997
- The ThinPrep Pap TestActa Cytologica, 1997
- Comparison of the CytoRich System with Conventional Cervical CytologyActa Cytologica, 1997
- Litigation cells: Definition and observations on a cell type in cervical vaginal smears not addressed by the Bethesda systemDiagnostic Cytopathology, 1994
- Problem Areas in Pathology Practice Uncovered by a Review of Malpractice ClaimsThe American Journal of Surgical Pathology, 1994
- The Papanicolaou Test for Cervical Cancer DetectionJAMA, 1989